Although some studies have shown that IL-5 may promote cell metastasis in esophageal tumors in which it is produced and secreted [24,40,42], expression studies in epithelial ovarian cancer documented its presence in the peritoneal cavity, with significantly higher levels in benign versus malignant tumors [43], further confirming its protective role [44]. Here, IL5 is linked to ovarian carcinoma.